Vilhelm Wessman

Mr. Vilhelm R.
Wessman is a Co-Chairman at Aztiq Pharma Partners ehf, a Chairman at Lotus Pharmaceutical Co., Ltd., an Executive Chairman at Alvotech, an Executive Chairman at Alvotech hf, a Chairman & Chief Executive Officer at Alvogen Emerging Markets Holdings Ltd., a Chairman at Adalvo Ltd. and a Chairman & Chief Executive Officer at Alvogen Lux Holdings SARL. He is on the Board of Directors at Aztiq Pharma Partners SARL, Fuji Pharma Co., Ltd., Alvogen Aztiq AB, Iceland Chamber of Commerce, Alvogen Ipco SARL, Kunwha Pharmaceutical Co., Ltd. and Norwich Clinical Services Pvt Ltd. Mr. Wessman was previously employed as a Chairman by Alvotech Holdings SA, a Chief Executive Officer by Alvogen Iceland ehf, a Chairman & Chief Executive Officer by Alvogen, Inc., a Chief Executive Officer by Watson Pharmaceuticals, Inc., a President & Chief Executive Officer by Delta ehf, a Founder by Almaject, Inc., a Chairman & Chief Executive Officer by Alvogen Iceland ehf, a Chairman & Chief Executive Officer by Alvogen Pharma US, Inc., a Chief Executive Officer by Samskip GmbH, and a Lecturer by University of Iceland.
He also served on the board at Actavis Group ehf and Alvogen Korea Co., Ltd. He received his undergraduate degree from the University of Iceland.